로딩 중…
지수 로딩 중…
Korea Arlico Pharm Co.,Ltd.
260660· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩2,610-0.57%
2026-06-19
Price Chart
Korea Arlico Pharm Co.,Ltd.-38.22%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 40.00B KRW |
| Revenue | 199.14B KRW |
| Net Income | -605.3M KRW |
| Total Assets | 170.71B KRW |
| Net Assets | 76.51B KRW |
| Employees | 242 |
| Value | |
| P/B | 0.52x |
| P/S | 0.20x |
| FCF Yield | 17.21% |
| Profitability | |
| ROE | -0.79% |
| ROA | -0.35% |
| Op. Margin | -0.89% |
| Revenue Growth | -4.09% |
| Earnings Growth | -255.54% |
| Financial Health | |
| Debt Ratio | 223.12% |
| Total Debt | 11.82B KRW |
| FCF | 6.88B KRW |
| Cash | 17.87B KRW |
| Current Ratio | 1.09x |
| Dividend | |
| Div. Yield | 2.86% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -38.22% |
| 1M Return | -15.94% |
| From 52W High | -54.69% |
| 1Y MDD | -50.59% |
| Trading | |
| Volume | 148,156 shares |
| Foreign Own. | 4.40% |
| Per Share | |
| EPS | -106 KRW |
| BPS | 5,096 KRW |
Company Info
Alico Pharmaceutical, established in 1992, manufactures and sells pharmaceuticals, having been listed on the KOSDAQ market in 2018. Its core businesses encompass domestic pharmaceutical sales, contract manufacturing organization (CMO), export of pharmaceuticals and goods, and the development and sale of medical devices, health functional foods, and cosmetics. The company has achieved external growth and profitability by focusing on profitable specialized pharmaceutical renewals, efficient production systems, and a low-cost, high-efficiency sales network. Alico Pharmaceutical is headquartered in Seocho-gu, Seoul.